Article
Effects of PNPLA3, TM6SF2 and SAMM50 on the development and severity of non-alcoholic fatty liver disease in children.
Pediatric obesity - 1 Feb 2022
Lee Kyung Jae, Moon Jin Soo, Kim Nan Young, Ko Jae Sung
Abstract excerpt
BACKGROUND: Although genetic variants of PNPLA3, TM6SF2 and SAMM50 have been reported to increase the risk of non-alcoholic fatty liver disease (NAFLD), no pediatric studies have evaluated the association between SAMM50 and NAFLD. OBJECTIVE: This study aimed to investigate the risk factors, including genetic variants, of pediatric NAFLD. METHODS: NAFLD was defined as the presence of hepatic steatosis on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
